← Insider buys
DCPH

Deciphera Pharmaceuticals, Inc.

EVP and Chief Medical Officer Matthew L Sherman sold $35K of Deciphera Pharmaceuticals, Inc.

Sold$35,234
$14.47Price
2,435Shares
−3%Stake

What DCPH did after the filing

Prices for DCPH after this filing aren't in yet.

Traded Tue, Jan 16. Filed Thu, Jan 18, 11:15 AM ET, during the session. Not investment advice.